Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: A cohort study

Journal of Viral Hepatitis

Volumn 16, Issue 6, 2009, Pages 437-443

  Ikeda, K ^a   Kobayashi, M ^a   Someya, T ^a   Saitoh, S ^a   Hosaka, T ^a   Akuta, N ^a   Suzuki, F ^a   Suzuki, Y ^a   Arase, Y ^a   Kumada, H ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Hepatitis B virus; Hepatocellular carcinogenesis; Liver cirrhosis; Occult hepatitis B virus infection; Proportional hazard model

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HERBACEOUS AGENT; VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANTIGEN DETECTION; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HEPATITIS B; HUMAN; JAPANESE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HUMANS; JAPAN; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 65449174853     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01085.x     Document Type: Article

References (47)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of worldwide frequency of twelve major cancers. Bull World Health Organ 1984 62 : 163 182. (Pubitemid 14113756)
2. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986 6 : 729 738. (Pubitemid 16038197)
3. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: Clinico-pathological features and results of surgical treatment. Ann Surg 1990 211 : 277 287. (Pubitemid 20105980)
4. Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990 8 : S18 S23. (Pubitemid 20154750)
5. Ikeda K, Saitoh S, Koida I et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis - a prospective observation of 795 cases with viral and alcoholic cirrhosis. Hepatology 1993 18 : 47 53. (Pubitemid 23193616)
6. Tsukuma H, Hiyama T, Tanaka S et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993 328 : 1797 1801. (Pubitemid 23174709)
7. Ikeda K, Saitoh S, Suzuki Y et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998 28 : 930 938. (Pubitemid 28275969)
8. Prince AM, Szmuness W, Michon J et al. A case-control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer 1975 16 : 376 383.
9. Ohnishi K, Iida S, Iwama S et al. The effect of chronic habitual alcohols intake on the development of liver cirrhosis and hepatocellular carcinoma. Relation to hepatitis B surface antigen carriage. Cancer 1982 49 : 672 677. (Pubitemid 12165423)
10. Lam KC, Yu MC, Leung JWC, Henderson BE. Hepatitis B virus and cigarette smoking: Risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res 1982 42 : 5246 5248. (Pubitemid 13223176)
11. Kaneko S, Muller RH, Feinstein SM et al. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A 1989 86 : 312 316. (Pubitemid 19036376)
12. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991 163 : 397 399.
13. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993 17 : 538 544. (Pubitemid 23115495)
14. Liang TJ, Baruch Y, Ben-Porath E et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991 13 : 1044 1051.
15. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 1998 54 : 249 255. (Pubitemid 28185416)
16. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999 341 : 22 26. (Pubitemid 29293716)
17. Takeuchi M, Fujimoto J, Niwamoto H, Yamamoto Y, Okamoto E. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig Dis Sci 1997 42 : 2264 2269. (Pubitemid 28004987)
18. Chemin I, Zoulim F, Merle P et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001 34 : 447 454. (Pubitemid 32240826)
19. Sheu JC, Huang GT, Shih LN et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992 103 : 1322 1327.
20. Paterlini P, Driss F, Pisi E, Franco D, Berthelot P, Brechot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993 17 : 20 29. (Pubitemid 23027379)
21. Lee DS, Huh K, Lee EH, Lee DH, Hong KS, Sung YC. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of co-infection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol 1997 12 : 855 861. (Pubitemid 28088072)
22. Brechot C, Jaffredo F, Lagorce D et al. Impact of HBV, HCV, and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998 29 : 173 183. (Pubitemid 28352801)
23. Shintani Y, Yotsuyanagi H, Moriya K et al. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C. Cancer 2000 88 : 2478 2486. (Pubitemid 30331953)
24. Shiota G, Oyama K, Udagawa A et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000 62 : 151 158.
25. Tamori A, Nishiguchi S, Kubo S et al. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol 2003 71 : 492 498. (Pubitemid 37309918)
26. Pollicino T, Squadrito G, Cerenzia G et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004 126 : 102 110. (Pubitemid 38040728)
27. Yotsuyanagi H, Hashidume K, Suzuki M, Maeyama S, Takayama T, Uchikoshi T. Role of hepatitis B virus in hepatocarcinogenesis in alcoholics. Alcohol Clin Exp Res 2004 28 : 181S 185S. (Pubitemid 44139584)
28. Marusawa H, Osaki Y, Kimura T et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999 45 : 284 288. (Pubitemid 29333780)
29. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 2003 27 (8 Suppl. 47S 51S. (Pubitemid 36999200)
30. Yotsuyanagi H, Yasuda K, Iino S et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998 27 : 1377 1382. (Pubitemid 28227867)
31. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958 53 : 457 481.
32. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrica 1982 69 : 553 566.
33. Cox DR. Regression models and life tables. J R Stat Soc 1972 34 : 248 275.
34. SPSS Inc. SPSS for Windows Version 11.0 Manual. Chicago, IL, USA : SPSS Inc., 2001.
35. Beasley RP. Hepatitis B virus: the major etiology for hepatocellular carcinoma. Cancer 1988 61 : 1942 1956. (Pubitemid 18123472)
36. Matsubara K, Tokino T. Integration of hepatitis B virus may contribute to hepatocarcinogenesis. Mol Biol Med 1990 7 : 243 260. (Pubitemid 20283937)
37. Koshy R, Hofschneider PH. Transactivation by hepatitis B virus may contribute to hepatocarcinogenesis. Curr Topics Microbiol Immunol 1989 144 : 265 281.
38. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Po S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001 34 : 194 203. (Pubitemid 32591500)
39. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001 34 : 204 206. (Pubitemid 32591501)
40. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepatitis 2002 9 : 243 257. (Pubitemid 36002459)
41. Torbenson M, Thomas DL. Occult hepatitis B infection. Lancet Infect Dis 2003 2 : 479 486.
42. Brechot C, Degos F, Lugassy C et al. Hepatitis B virus DNA in patients with chronic liver disease and negative test for hepatitis B surface antigen. N Engl J Med 1985 312 : 270 276. (Pubitemid 15199365)
43. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002 40 : 4068 4071.
44. Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996 8 : 478 483. (Pubitemid 26280775)
45. Ikeda K, Kobayashi M, Someya T et al. Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis. Intervirology 2002 45 : 71 78. (Pubitemid 36160124)
46. Marrero JA, Lok ASF. Occult hepatitis B virus infection in patients with hepatocellular carcinoma: innocent bystander, cofactor, or culprit? Gastroenterology 2004 126 : 347 350. (Pubitemid 38040749)
47. Castillo I, Pardo M, Bartolome J et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004 189 : 7 14. (Pubitemid 38122323)